JCI-accredited · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Dr. Mehmet Teomete Medical Oncology

Dr. Mehmet Teomete

✓ Medically verified profile
Medical Oncology

Dr. Mehmet Teomete

✓ Medically verified profile
32+ years experienceLanguages: Turkish, EnglishOnline consultationAcibadem Atasehir Hospital · İstanbul
★★★★★ From 2,400+ verified Acibadem patient reviews
Dr. Mehmet Teomete

Quick answer

Dr. Mehmet Teomete is a Medical Oncology specialist at Acibadem Atasehir Hospital, İstanbul, with 32+ years of experience.

He treats breast cancer, early and triple-negative breast cancer, node-negative breast cancer, metastatic colorectal cancer, stage IIIB/IV non-small cell lung cancer, and rectal carcinoma, and provides adjuvant, second-line, platinum-based, docetaxel, and anthracycline chemotherapy, as well as adjuvant chemoradiotherapy. He consults in Turkish and English and offers online video consultation.

Profile

About Dr. Mehmet Teomete

Dr. Mehmet Teomete is a Medical Oncology specialist with 32 years of experience. His listed areas of expertise include metastatic colorectal cancer, rectal carcinoma, stage IIIB/IV non-small cell lung cancer, adjuvant chemotherapy, platinum-based chemotherapy, docetaxel chemotherapy, anthracycline chemotherapy and adjuvant chemoradiotherapy.

Dr. Teomete graduated from Ankara University Faculty of Medicine in 1994. He was at Marmara University Faculty of Medicine from 2005 to 2009 for Subspecialty Training, and completed Medical Oncology at Marmara University Faculty of Medicine in 2009. He was an Internal Medicine Specialist at Haydarpasa Numune Training and Research Hospital from 2003 to 2005, and joined Acibadem Health Group in 2004. He practises at Acibadem Atasehir Hospital in İstanbul, Türkiye.

The profile lists 12 publications dated between 2007 and 2009. The listed work includes breast cancer, colorectal cancer, non-small cell lung cancer, rectal carcinoma, pulmonary toxicity during docetaxel chemotherapy, and glycemic control with platelet activity in type 2 diabetes mellitus. Dr. Teomete speaks Turkish and English, and online consultation is available for patients who wish to speak with the doctor before travelling.

Clinical Focus

Areas of Expertise

Conditions treated and procedures performed by this specialist.

Breast cancerEarly breast cancerTriple-negative breast cancerNode-negative breast cancerMetastatic colorectal cancerStage IIIB/IV non-small cell lung cancerRectal carcinomaAdjuvant chemotherapySecond-line chemotherapyPlatinum-based chemotherapyDocetaxel chemotherapyAnthracycline chemotherapyAdjuvant chemoradiotherapy
Background

Education

  • 2009Marmara University Faculty of Medicine Medical Oncology
  • 2003Haydarpasa Numune Training and Research Hospital Internal Medicine
  • 1994Ankara University Faculty of Medicine
Career

Professional Experience

  • 2010Trabzon Numune Training and Research Hospital / Medical Oncology Specialist
  • 2009–2010Erzurum Regional Training and Research Hospital / Medical Oncology Specialist
  • 2005–2009Marmara University Faculty of Medicine / Subspecialty Training
  • 2004Acibadem Health Group
  • 2003–2005Haydarpasa Numune Training and Research Hospital / Internal Medicine Specialist
  • 1998–2003Haydarpasa Numune Training and Research Hospital / Internal Medicine Assistant
  • 1996–1998Trabzon Merkez Çağlayan Health Center / General Practitioner
  • 1994–1996Trabzon Düzköy District Aykut Town Health Center / General Practitioner
Affiliations

Professional Memberships

  • Medical Oncology Society
  • Turkish Medical Association
Research

Selected Publications

  • Pregnancy a short time after multimodal therapy for bilateral breast cancer: a case report and review of literature J Oncol Pharm Pract September 21, 20101078155210384755 Timur Koca Zuleyha Akgun [email protected] Serap Baskaya Yucel Nihal Zerman Dag Mehmet Teomete
  • Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey Medical Oncology 001: 10.1007js12032-010-9463-x Gul Basaran, Nazlm Serdar Turhal, Devrim Cabukr Nevin Yurt, Gul Yurtseven, Mahmut Gumus, Mehmet Teomete, Faysal Dane and Perran Fulden Yumuk
  • 0utcome of metastatic colorectal cancer patients receiving second line chemotherapy in Marmara University Hospital F. Dane, M. Gumus, A. Ozturk, F. Yumuk, S. Iyikesici, G. Basaran, D. Cabuk, M. Teomete and N. S. Turhal 18S (June 20 Supplement), 2007: 14588© 2007 American Society of Clinical Oncology Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 25, No
  • Impact of dose reductions of platinum compounds on survival in stage IIIB/IV non-small cell lung cancer (NSCLC) P. F. Yumuk, M. Teomete, F. Dane, D. Cabuk, G. Basaran and N. S. Turhal Marmara University Medical School Hospital, Istanbul, Turkey 15S (May 20 Supplement), 2009: e19055© 2009 American Society of Clinical Oncology Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 27, No
  • Pulmonary toxicity in patients receiving docetaxel chemotherapy U. Kefeli, P. F. Yumuk, B. Ceyhan, F. Dane, B. Eroglu, D. Cabuk, G. Basaran, M. Teomete and N. S. Turhal. No 15S (May 20 Supplement), 2009: e13532© 2009 American Society of Clinical Oncology Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 27,
  • Benefit from adjuvant anthracyclines according to hormone receptor status G. Atalay Basaran, D. Cabuk, M. Teomete, B. Gulluoglu, H. Kaya, F. Dane, P. F. Yumuk and N. S. Turhal Vol 26, No 15S (May 20 Supplement), 2008: 11513© 2008 American Society of Clinical Oncology Marmara University Hospital, Istanbul, Turkey Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition).
  • The relationship between glycemic control and platelet activity in type 2 diabetes mellitus Received May 24, 2007; received in revised form January 7, 2008; accepted January 18, 2008. published online March 25, 2008. Refik Demirtunc, Dursun Duman, Melih Basar, Mustafa Bilgi, Mehmet Teomete, Tayfun Garip
  • A case of Kikuchi-Fujimoto disease misdiagnosed as Hodgkin’s lymphoma: the importance of second opinion. J aVON. 2009 Apr-Jun;14(2):309-11 Dane F, Ozturk MA, Tecimer T, Atasoy BM, Cabuk D, Yumuk PF, Basaran G, Teomete M, Turhal NS.
  • Clinical outcome of triple-negative (TN) breast cancer (BC) D. Cabuk, G. Basaran, H. Kaya, B. Gulluoglu, M. Teomete, F. Dane, P. F. Yumuk and N. S. Turhal (Post-Meeting Edition). Vol 26, No 15S (May 20 Supplement), 2008: 11526 © 2008 American Society of Clinical Oncology MUTFH, Istanbul, Turkey Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings
  • Clinical features and outcome of adjuvant chemoradiotherapy in Turkish rectal carcinoma patients: Single institution experience F. Dane, M. Gumus, M. A. Ozturk, D. Cabuk, M. B. Atasoy, P. F. Yumuk, G. Basaran, M. S. Iyikesici, M. Teomete, U. Abacioglu and N. S. Turhal Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Marmara University Medical Oncology, Istanbul, Turkey; Marmara University Radiation Oncology, Istanbul, Turkey
  • Clinical outcome of node-negative (NN) breast cancer (BC) patients Marmara University Hospital, Istanbul, Turkey Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition). G. Atalay Basaran, D. Cabuk, F. Dane, M. Teomete, S. Iyikesici, E. Meltem, B. Gulluoglu, H. Kaya, U. AbaCloglu, F. Yumuk and S. Turhal
  • 0utcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey Journal of Thoracic Oncology: August 2007 – Volume 2 – Issue 8 – p S701 doi: 10.1 097jOl.JTO. 0000284031.87598.62 Yumuk, Perran F.; Teomete, Mehmet; Dane, Faysal; Cabuk, Devrim; Caglar, Hale B.; Abacioglu, Ufuk; Basaran, Gul; Turhal, Nazim S.
Good to Know

Frequently Asked Questions

What is Dr. Mehmet Teomete's specialty?
Dr. Mehmet Teomete is a specialist in Medical Oncology at Acibadem. For a personalised assessment, the Acibadem international patient team can review your medical history and reports and explain the suitable next steps.
Which hospital does Dr. Mehmet Teomete practise at?
Dr. Mehmet Teomete sees patients at Acibadem Atasehir Hospital in İstanbul. The international patient team can confirm current availability and help you plan a consultation or visit.
What languages can I use when consulting Dr. Mehmet Teomete?
Consultations with Dr. Mehmet Teomete are supported in Turkish and English. In addition, Acibadem provides multilingual coordination and interpreter support so international patients can communicate clearly throughout their care.
How can I book an appointment with Dr. Mehmet Teomete?
You can request an appointment with Dr. Mehmet Teomete using the appointment form on this page, or by contacting the Acibadem international patient team by phone or WhatsApp. After you share your details, the team checks availability and confirms your appointment, usually within 24 hours.
Is an online video consultation available with Dr. Mehmet Teomete?
Yes. Dr. Mehmet Teomete offers online video consultations, so you can discuss your condition and reports with the specialist before making any travel arrangements. The international patient team can help you schedule a secure video visit.
How many years of experience does Dr. Mehmet Teomete have?
Dr. Mehmet Teomete has around 32 years of professional experience in Medical Oncology. A summary of education, experience and professional memberships is available on this page.
Can international patients arrange treatment with Dr. Mehmet Teomete?
Yes. Acibadem supports international patients end to end — from the first consultation and treatment planning through appointment scheduling, interpretation during the stay and follow-up after returning home. Sharing your case for an initial assessment is free of charge.
How do I get a second opinion involving Dr. Mehmet Teomete?
You can request an independent review of your diagnosis and proposed treatment. Share your medical reports through the consultation or "Ask a Doctor" form on this site, and the team will arrange a specialist review and explain the available options.
Care without borders

A dedicated team, from first message to follow-up

Our international patient office coordinates your appointment, travel and treatment at JCI-accredited Acıbadem hospitals — and stays with you in your own language, every step of the way.

Book an Appointment

Schedule your appointment with Dr. Mehmet Teomete

Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.

  1. 1
    Choose your date & timePick a preferred day and time slot for your visit.
  2. 2
    Share your detailsTell us how to reach you and anything we should know.
  3. 3
    We confirm with youOur team confirms the appointment by phone or email.
Why patients choose Acıbadem
35+Years of expertise
90+Countries served
20+Languages spoken
24/7Patient support
Prefer to talk now?
Appointment Request

Request your appointment

This request goes directly to this doctor’s schedule.

Dr. Mehmet Teomete Appointment with Mehmet Teomete Medical Oncology

Your information stays strictly confidential and is used only to arrange your care.

Where

Hospitals

Departments

Medical Units

Treatments

Treatments Performed

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.